Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The design of cellulosic based membranes that do not activate complement.

R J Johnson1

  • 1Baxter Healthcare Corporation, Round Lake, IL 60073.

Medical Progress Through Technology
|January 1, 1989
PubMed
Summary

Researchers explored ways to reduce complement activation during extracorporeal therapies. Modified materials like Cellulose Triacetate and Hemophan limit inflammatory responses by reducing C3b binding and enhancing regulation, improving patient safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osteopontin expression in human crescentic glomerulonephritis.

Kidney international·2000
Same author

The diagnostic value of positron emission tomography (PET) with radiolabelled fluorodeoxyglucose (18F-FDG) in head and neck cancer.

The Journal of laryngology and otology·1999
Same author

Clinicopathologic correlations in lupus nephritis in Lima, Peru.

Nephron·1999
Same author

Calreticulin is transported to the surface of NG108-15 cells where it forms surface patches and is partially degraded in an acidic compartment.

Journal of neuroscience research·1999
Same author

KDEL proteins are found on the surface of NG108-15 cells.

Brain research. Molecular brain research·1999
Same author

Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA)

Lancet (London, England)·1999

Area of Science:

  • Biomaterials Science
  • Immunology
  • Nephrology

Background:

  • Complement activation by biomaterials in extracorporeal therapies causes inflammation.
  • Systemic exposure to C5a can lead to pathological outcomes.
  • Non-specific complement activation necessitates strategies for material modification.

Purpose of the Study:

  • To identify and evaluate methods for limiting complement activation on biomaterials.
  • To investigate surface modifications that reduce C3b deposition and convertase formation.
  • To explore strategies enhancing complement regulatory pathways.

Main Methods:

  • Surface modification of cellulosic materials to reduce nucleophilic sites (e.g., Cellulose Triacetate).
  • Assessment of C3b binding capacity compared to standard materials (e.g., cuprophan).

Related Experiment Videos

  • Investigation of material effects on complement regulatory factors (H and I) using Hemophan.
  • Development of novel surface modifications using dicarboxylic acid anhydrides.

    • Main Results:

    • Cellulose Triacetate membranes exhibit significantly reduced C3b binding (one-third of cuprophan).
    • Hemophan demonstrates potential to limit complement activation via enhanced regulation of bound C3b.
    • Dicarboxylic acid anhydride modifications show promise for creating materials with minimal complement activation potential.

    Conclusions:

    • Material surface properties critically influence complement activation.
    • Reducing C3b deposition and enhancing regulatory mechanisms are effective strategies.
    • Novel biomaterial modifications offer a path to safer extracorporeal therapies with reduced inflammatory complications.